Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting
Authors
Keywords
Tigecycline, Multidrug resistance, Intensive care, Organ failure, Severe infections
Journal
INTENSIVE CARE MEDICINE
Volume 40, Issue 7, Pages 988-997
Publisher
Springer Nature
Online
2014-05-28
DOI
10.1007/s00134-014-3323-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tigecycline use in serious nosocomial infections: a drug use evaluation
- (2016) Matteo Bassetti et al. BMC INFECTIOUS DISEASES
- Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the “untreatable bacteria”: time to change direction
- (2013) José-Artur Paiva INTENSIVE CARE MEDICINE
- Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing
- (2013) Mathias W. Pletz et al. INTENSIVE CARE MEDICINE
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
- (2013) Mario Tumbarello et al. INTENSIVE CARE MEDICINE
- Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies
- (2013) M. Bassetti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies
- (2013) P. Montravers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies
- (2013) C. Eckmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies
- (2013) W. R. Heizmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies
- (2013) X. Guirao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effectiveness and Safety of Tigecycline: Focus on Use for Approved Indications
- (2012) K. Z. Vardakas et al. CLINICAL INFECTIOUS DISEASES
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
- (2012) P. Prasad et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
- (2010) Zhangjing Chen et al. BMC INFECTIOUS DISEASES
- A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections
- (2010) S. Towfigh et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
- (2009) David Gardiner et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*
- (2009) Jean Chastre et al. CRITICAL CARE MEDICINE
- Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry
- (2008) Daniel Curcio et al. Brazilian Journal of Infectious Diseases
- Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
- (2008) Cristina Tanaseanu et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin
- (2008) Carlos Bergallo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
- (2008) I. Florescu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
- (2008) K. Vasilev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit
- (2008) S. Swoboda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started